S. Matsubara

发表

mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions

S. Takao, S. Matsubara, Q. Ding, 2013, Scientific Reports.

A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.

A. Nakagawara, S. Takao, T. Muramatsu, 1993, Cancer research.

Expression of α-catenin in α-catenin–deficient cells increases resistance to sphingosine-induced apoptosis

M. Ozawa, S. Matsubara, 2001, The Journal of cell biology.

Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.

D. Curiel, P. Reynolds, M. Yamamoto, 2000, Cancer research.

A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse.

T. Muramatsu, K. Kadomatsu, S. Matsubara, 1991, Biochemical and biophysical research communications.

Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133+ pancreatic cancer cells

S. Takao, M. Yoshimitsu, S. Matsubara, 2015, Human Cell.

Expression of (cid:2) -catenin in (cid:2) -catenin–deﬁcient cells increases resistance to sphingosine-induced apoptosis

M. Ozawa, S. Matsubara, 2001 .

Expression of α-catenin in α-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures

M. Ozawa, S. Matsubara, 2004, Oncogene.

Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.

D. Curiel, P. Reynolds, T. Muramatsu, 2002, Journal of pediatric surgery.

A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product.

T. Muramatsu, M. Tomomura, K. Kadomatsu, 1990, The Journal of biological chemistry.

Arginase activity in the cotyledons of soybean seedlings

S. Matsubara, Yonezo Suzuki, 1984 .

A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development.

T. Muramatsu, M. Ozawa, S. Matsubara, 1992, Journal of biochemistry.

Structure of a retinoic acid-responsive gene, MK, which is transiently activated during the differentiation of embryonal carcinoma cells and the mid-gestation period of mouse embryogenesis.

T. Muramatsu, M. Tomomura, K. Kadomatsu, 1990, The Journal of biological chemistry.

Chromosomal localization of two cell surface-associated molecules of potential importance in development: Midkine (Mdk) and basigin (Bsg)

J. Guénet, T. Muramatsu, S. Matsubara, 2004, Mammalian Genome.

The Upstream Sequence of a New Growth/Differentiation Factor, Midkine (MK), Mediates Developmentally Regulated lac Z Gene Expression in Transgenic Mice

K. Yamamura, T. Muramatsu, T. Kaname, 1994 .

Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor.

T. Muramatsu, K. Kadomatsu, S. Matsubara, 1992, Journal of biochemistry.

Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells.

P. Chambon, P. Bouillet, P. Dollé, 1997, Genes & development.

Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer

S. Natsugoe, S. Takao, Tomomi Hayashi, 2012, Human Cell.

Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition

S. Takao, K. Kosai, M. Yoshimitsu, 2016, Molecular Cancer.

A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.

D. Curiel, P. Reynolds, M. Wang, 2001, Cancer research.

Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy

S. Takao, S. Matsubara, Q. Ding, 2012, Journal of hepato-biliary-pancreatic sciences.

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis

S. Takao, M. Yoshimitsu, S. Matsubara, 2014, Molecular Cancer.

miR-30 family promotes migratory and invasive abilities in CD133+ pancreatic cancer stem-like cells

S. Natsugoe, S. Takao, S. Matsubara, 2016, Human Cell.

Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133+ pancreatic cancer cells

S. Takao, M. Yoshimitsu, S. Matsubara, 2015, Human Cell.

Efficient transfection of primarily cultured porcine embryonic fibroblasts using the Amaxa Nucleofection system.

S. Takao, Masahiro Sato, S. Matsubara, 2007, Cloning and stem cells.

Expression of MUC17 Is Regulated by HIF1α-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer

S. Batra, S. Takao, S. Yonezawa, 2012, PloS one.

Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition

S. Takao, K. Kosai, M. Yoshimitsu, 2016, Molecular Cancer.

Prevention of Akt phosphorylation is a key to targeting cancer stem-like cells by mTOR inhibition

S. Takao, S. Matsubara, T. Kuwahata, 2020, Human Cell.

Expression of alpha-catenin in alpha-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures.

M. Ozawa, S. Matsubara, 2004, Oncogene.

Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity.

C. Pedraza, T. Muramatsu, S. Matsubara, 1994, Journal of biochemistry.

The midkine (MK) family of growth/differentiation factors: structure of an MK-related sequence in a pseudogene and evolutionary relationships among members of the MK family.

J. Guénet, T. Muramatsu, S. Matsubara, 1994, Journal of biochemistry.

Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).

T. Akiyama, C. Pedraza, T. Muramatsu, 1996, Oncogene.

Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer

S. Natsugoe, S. Takao, Tomomi Hayashi, 2011, Human Cell.

miR-30 family promotes migratory and invasive abilities in CD133+ pancreatic cancer stem-like cells

S. Natsugoe, S. Takao, S. Matsubara, 2016, Human Cell.